Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Respiratory syncytial virus RSV Vaccines - Biotech, Pharma and Life Science Channel

04:38 EDT 25th April 2014 | BioPortfolio

Respiratory syncytial virus (RSV) infection, which manifests primarily as bronchiolitis and/or viral pneumonia, is the leading cause of lower respiratory tract infection in infants and young children. In the US, RSV LRT infection develops annually in 4-5 million children, and more than 125,000 children are admitted per year for RSV-related illness. RSV disease is the no.1 cause of hospitalization in babies under a year of age in the US. While a monoclonal antibody is commercially available to help prevent RSV disease in infants and children at high risk for severe lung disease from RSV, a RSV vaccine still is not on the market. A number of RSV vaccine candidates have entered clinical development and further are to follow. Also, next generation antibodies against RSV with improved features are in the development pipeline as well as new therapies based on silencing RSV RNA or inhibiting key targets of the virus.

News Articles [703 Associated News Articles listed on BioPortfolio]

Theraclone Sciences Announces Identification of New Vulnerable Site on HIV Using Antibodies Discovered with Theraclone Technology

--Study Published in Immunity in Collaboration with The Scripps Research Institute and IAVI-- Theraclone Sciences, Inc., a therapeutic antibody discovery and developmen...

Report shows 20-year US immunization program spares millions of children from diseases

ATLANTA, April 24, 2014 /PRNewswire-USNewswire/ -- The CDC estimates that vaccinations will prevent more than 21 million hospitalizations and 732,000 deaths among children born in the last 20 years. D...

Scientists Find New Point of Attack on HIV for Vaccine Development

NEW YORK, April 24, 2014 /PRNewswire-USNewswire/ -- Scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) have discovered a new vulnerable sit...

GENOCEA Co-Founder Receives TIME Magazine’s TIME 100 Honor

Dr. David A. Sinclair Joins Annual List of World’s 100 Most Influential People Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company de...

Transfection Technology Market (Reagent-based method, Instrument-based Method and Virus-based method) Expected to Reach USD 768.2 Million Globally in 2019: Transparency Market Research

ALBANY, New York, April 24, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Transfection Technology Market (Reagent-based method, Instrument-based met...

Greater Reductions in Exacerbations Remains an Open Area of Opportunity in the Chronic Obstructive Pulmonary Disease Market

BURLINGTON, Mass., April 24, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. and European pulmonologists agree that a therapy offering a greater reduction in exacerbations...

Gateway Analytical to Present with the FDA on Chemically Specific Analysis of Orally Inhaled Drug Products at the Respiratory Drug Delivery Conference in Puerto Rico

PITTSBURGH, April 24, 2014 /PRNewswire-iReach/ -- Gateway Analytical announced today that they will be exhibiting and presenting at the upcoming Respiratory Drug Delivery (RDD) conference in Fajardo,...

Oncothyreon Announces First Quarter 2014 Financial Results Conference Call

SEATTLE, April 24, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, May 1, 2014 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific)...

A Common Sense Approach to Appropriate Drug Use

SAN DIEGO, April 24, 2014 /PRNewswire/ -- We at Zogenix  have reviewed the letter to Vermont Governor Peter Shumlin signed by the Center for Lawful Access and Abuse Deterrence (CLAAD), ...

Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project

BEIJING, April 24, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60 million free gov...

Events [0 Results]

None

Companies [195 Associated Companies listed on BioPortfolio]

Dimension Therapeutics

Dimension Therapeutics is a gene therapy company focused on developing novel therapies to treat rare diseases. Launched by Fidelity Biosciences in 2013, the Dimension team compris...

SynteractHCR

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in al...

Promise Healthcare

Headquartered in Boca Raton, Florida, Promise Healthcare, Inc. (www.promisehealthcare.com) is one of the largest long-term acute care (LTAC) hospital organizations in the country....

Allegro Diagnostics Corp.

Allegro Diagnostics’ molecular testing platform utilizes gene expression of normal epithelial cells in the respiratory tract to detect early signs of lung cancer and diseases...

Carex Health Brands & Roscoe Medical

Roscoe Medical, headquartered in Strongsville, Ohio, is a major manufacturer and distributor of innovative healthcare products that promote independence and better living in the h...

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to...

TKL Research, Inc.

TKL Research is a full-service, international CRO offering complete Phase 1-4 clinical trial services, often in enrollment-driven therapeutic areas. The company has a solid reputa...

Advanced BioScience Laboratories, Inc. (ABL)

Profectus is a clinical-stage biotechnology company developing novel vaccines to prevent and treat major chronic viral infectious diseases and associated cancers for which standar...

Promise Healthcare, Inc.

Based in Boca Raton, Florida, Promise Healthcare is one of the largest long-term acute care (LTAC) hospital organizations in the country. With more than 2,000 staff members and 13...

Barlow Respiratory Hospital

Barlow Respiratory Hospital is the only not-for-profit, long-term, acute care respiratory hospital in Southern California. We specialize in caring for critically ill, complex pati...

Clinical Trials [2342 Associated Clinical Trials listed on BioPortfolio]

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

The primary purpose of this study is to determine the pharmacokinetic properties (what the body does to maraviroc) and to determine a suitable dosing schedule of maraviroc in HIV-1 infecte...

Study to Evaluate the Safety and Immunogenicity of Poly ICLC (Hiltonol) in Healthy Volunteers

Vaccines induce protective immunity against numerous infectious diseases. However, current vaccines have limited efficacy against challenging infections like tuberculosis, malaria and HIV....

Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump

Patients who completed the conventional treatment against HCV and relapsed (the virus appeared again in their blood) have no effective therapy.

Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study

Background and rationale Chronic hepatitis B is the most common cause of liver cirrhosis and hepatocellular carcinoma worldwide.(1) Antiviral therapy with oral nucleoside analogs and inter...

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

This Post Marketing Surveillance study will be performed as an open-label, prospective, non-interventional, uncontrolled study in Human immunodeficit Virus-1 (HIV-1) infected patients. Dat...

A Multiple Dose Study of MK-5172 in Hepatitis C-Infected Participants (MK-5172-010)

This study will compare hepatic pharmacokinetics (PK) derived from liver tissue to plasma PK after administration of MK-5172 to participants with chronic hepatitis C virus (HCV) infection....

Safety Study of GNbAC1 in Multiple Sclerosis Patients

The purpose of this study is to assess the safety and tolerability of single ascending doses, as well as of repeated administrations of GNbAC1 in MS patients. Scientific research has show...

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49

The purpose of this study is to test an investigational vaccine known as "VAX161C." An "investigational" vaccine is one that is not licensed for commercial use in the by the United States...

Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure

Although the advent of advanced medical support for respiratory failure, the mortality rate of acute severe respiratory failure is still high and the life quality is frequently compromised...

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

This study will determine the HCV antiviral efficacy, safety, and tolerability of treatment with Ledipasvir/Sofosbuvir (LDV/SOF) fixed-dose combination (FDC) for participants with genotype...

PubMed Articles [5203 Associated PubMed Articles listed on BioPortfolio]

Aspirin Desensitization: Useful Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Aspirin-Exacerbated Respiratory Disease (AERD)?

Aspirin intolerance syndrome is due to disturbances in the arachidonic acid metabolism implicating both the lipoxygenase and cyclooxygenase pathways. This results in imbalances of eicosanoid, leukotri...

Management of chronic rhinosinusitis in asthma patients: is there still a debate?

The united airway concept in which upper and lower respiratory conditions are present in one patient requires special consideration. There is some evidence linking chronic rhinosinusitis and asthma, b...

Good's Syndrome, CVID, and Selective Antibody Deficiency in Patients with Chronic Rhinosinusitis.

Good's syndrome and common variable immune deficiency (CVID) are associated with chronic rhinosinusitis. Good's syndrome is characterized by hypogammaglobulinemia, B-cell depletion, variable defects i...

Non-invasive respiratory volume monitoring to detect apnea in post-operative patients: case series.

Obstructive sleep apnea (OSA) is a potential independent risk factor for postoperative complications, adverse surgical outcomes, and longer hospital stays. Obese patients with OSA have increased post-...

Spondyloarthritis in sub-saharan Africa.

Spondyloarthritis (SpA) is generally uncommon in sub-Saharan Africa, in part because of the rarity of HLA-B27 in this region. However, the relationship between HLA-B27 and SpA, particularly ankylosing...

Engaging adaptive immunity with biomaterials.

Adaptive immune responses, characterized by T cells and B cells engaging and responding to specific antigens, can be raised by biomaterials containing proteins, peptides, and other biomolecules. How d...

Depuration kinetics of hepatitis A virus in clams.

The efficacy and dynamic of depuration for the removal of hepatitis A virus (HAV) contamination were evaluated under experimental conditions using Manila clams previously subjected to bioaccumulation...

Adaptive Responses of Mitochondria to Mild Copper Deprivation Involve Changes in Morphology, OXPHOS Remodeling and Bioenergetics.

Copper is an essential cofactor of complex IV of the electron transfer chain, and it is directly involved in the generation of mitochondrial membrane potential. Its deficiency induces the formation of...

Current treatment and management of dystrophinopathies.

• Duchenne muscular dystrophy (DMD), the most common and severe type of dystrophinopathy, is a progressive disease affecting primordially skeletal and cardiac muscle. A coordinated multidisciplinary...

Reply to "CD8+ T Cells Are Essential for Controlling Acute Friend Virus Infection in C57BL/6 Mice".

Medical and Biotech [MESH] Definitions

Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.

Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.

An acute inflammatory disease of the upper RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.

The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.

Search BioPortfolio:
Advertisement
review and buy Respiratory syncytial virus RSV Vaccines market research data and corporate reports here

Channels Quicklinks

Advertisement